Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

ExpreS2ion Biotech Holding AB (EXPRS2)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
24.90 +0.35    +1.43%
08/08 - Closed. Currency in SEK
Type:  Equity
Market:  Sweden
ISIN:  SE0023261292 
S/N:  2658346
  • Volume: 3,239
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 24.05 - 25.70
ExpreS2ion Biotech 24.90 +0.35 +1.43%

ExpreS2ion Biotech Holding AB Company Profile

 
Get an in-depth profile of ExpreS2ion Biotech Holding AB, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

18

Equity Type

ORD

ExpreS2ion Biotech Holding AB (publ), a biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally. The company’s lead asset is ES2B-C001, a therapeutic vaccine which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2. It is also developing ES2B-I002, a cytomegalovirus vaccine program to treat infectious diseases, as well as vaccines for Nipah virus, Malaria, and influenza. In addition, the company offers a human clinical Phase III-validated technology platform for the development and production of the active material in vaccines under the GlycoX-S2. Further, it out licenses its ExpreS2 platform to research institutes and pharmaceutical companies; and sells ExpreS2 test kits and reagents for research purposes or diagnostic applications. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.

Contact Information

Address Rönnowsgatan8C
Helsingborg, 252 25
Sweden
Phone -
Fax -

Top Executives

Name Age Since Title
Martin Roland Jensen 65 2010 Chairman of the Board
Rupert Bartsch - 2022 Member of Oncology Scientific Advisory Board
Mark R. Schleiss - 2023 Member of Infectious Diseases Scientific Advisory Board
Karin Garre 68 2021 Independent Director
Stanley A. Plotkin 92 2023 Member of Infectious Diseases Scientific Advisory Board
Allan Randrup Thomsen - 2023 Member of Infectious Diseases Scientific Advisory Board
Jakob Knudsen 57 2017 Independent Director
Giuseppe Curigliano - - Member of Oncology Scientific Advisory Board
Javier Cortes - 2022 Member of Oncology Scientific Advisory Board
Sara Sande 50 2021 Independent Director
Daniel Lenihan - 2022 Member of Oncology Scientific Advisory Board
Michael Andersson - 2022 Member of Oncology Scientific Advisory Board
Lone Graff Stensballe - 2023 Member of Infectious Diseases Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EXPRS2 Comments

Write your thoughts about ExpreS2ion Biotech Holding AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email